Consortia funded through the IMI Ebola+ Programme Supported by the European Commission Brings together London School of Hygiene and Tropical Medicine, Inserm, University of Oxford, Le Centre Muraz, Bavarian Nordic A/S, Vibalogics, the Grameen Foundation and World Vision of Ireland with Janssen Pharmaceutical Companies to help accelerate Ad26 – MVA Ebola vaccine development and patient education
